Best Life Sciences Companies in India
The 2115 best Life Sciences companies in India in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Cochlear.
India's Life Sciences sector has 2,115 companies tracked in our directory, ranked by disclosed equity funding and recent momentum — and the $3.3B in total disclosed capital tells you this is a serious industrial base, not a startup hobby. MedGenome leads the funding table at $217M, with Kapiva at $51M and Fullife at $45M rounding out the top tier. The sector's one unicorn and a concentrated roster of institutional backers, including BIRAC, the Department of Biotechnology, and IKP Knowledge Park, signal that patient, government-linked capital is doing the heavy lifting here.
What's actually moving the needle right now? Hot themes are stem cell banking, cell-based therapies, diagnostic biotechnology, and gene delivery systems, while coverage of older verticals stays flat. Healthcare and life sciences apps are clocking median install growth of roughly 43% YoY, which I'd read as consumer demand finally catching up to the science. The global life sciences market is tracking toward substantial scale at a 10.2% CAGR, and India's positioning inside that growth is hardening fast, as Sai Life Sciences' IPO plans with an Rs 800 crore fresh issue make clear. The companies you find here earned their rankings on disclosed funding and momentum, full stop.
- Vaccine maker Bharat Biotech said to mull $500 million IPO
- HRV Pharma, Virtual Manufacturing, and the Structural Causes of Chronic Drug Sho
- Delivering higher output at lower costs
Our analysis of 50 Life Sciences companies
$1.2b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.
Ranked: Best Life Sciences companies in India
| # | Company | Disclosed funding | Last round | Revenue | Revenue YoY | Employees | Founder | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Goapptiv A technology-driven business services provider in healthcare 76Moat top 12%Funding top 29%Growth top 30%Market top 32% All 10 signals ▾Moattop 12% Fundingtop 29% Growthtop 30% Markettop 32% Fin. healthtop 32% Talenttop 38% Producttop 41% Techtop 47% Globalbottom 37% Newsbottom 22% Moat: Top 1% by revenue among 98 tracked Life Sciences Tech companies · Editorial + unicorn rating 7/10 Funding: Raised $31.7M across 6 rounds · 6 rounds over 10 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 76/100 | $32M | 14 mo ago | $187M FY2025 | +39% | 75 | Rajasekhar Parcha Co-Founder & CEO | — | — | — |
| 2 | Ascent Health & Wellness Solutions Provider of pharmaceutical supply chain solutions 72Market top 19%Moat top 20%Funding top 26%Talent top 28% All 10 signals ▾Markettop 19% Moattop 20% Fundingtop 26% Talenttop 28% Growthtop 30% Producttop 30% Innovationtop 38% Fin. healthtop 43% Globalbottom 37% Techbottom 16% Market: 1,739 employees (top 2% of Healthtech) · Revenue ~$162M Moat: Top 1% by revenue among 98 tracked Life Sciences Tech companies · Editorial + unicorn rating 8/10 rank vs industry peers · Fliar Intelligence Index 72/100 | $342M | 38 mo ago | $162M FY2025 | — | 1,739 | Harsh Parekh Co-Founder | — | — | — |
| 3 | LifeCell A stem cell banking company specializing in cord blood and tissue preservation 83Fin. health top 11%Tech top 14%Moat top 20%Market top 24% All 10 signals ▾Fin. healthtop 11% Techtop 14% Moattop 20% Markettop 24% Fundingtop 36% Growthtop 46% Producttop 49% Talentbottom 49% Globalbottom 37% Newsbottom 21% Fin. health: Revenue ~$101M (FY2022) · Net margin 45.7% Tech: 46 technologies across 7/8 capability areas · Cloud: Amazon Alb, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 83/100 | $61M | 26 mo ago | $101M FY2025 | +146% | 1,188 1,188 → 2,658 (+124%) · sector median +32% | Mayura Jain CEO & Managing Director | — | — | 1 partnership |
| 4 | MedGenome Provider of DNA sequencing, bioinformatics, and multiomics services 83Funding top 20%Fin. health top 21%Moat top 22%Market top 25% All 10 signals ▾Fundingtop 20% Fin. healthtop 21% Moattop 22% Markettop 25% Talenttop 28% Techtop 32% Producttop 36% Growthtop 50% Globalbottom 45% Newsbottom 40% Funding: Raised $217M across 10 rounds · 10 rounds over 13 yrs (0.8/yr) Fin. health: Revenue ~$48.1M (FY2024) · Net margin 17.5% rank vs industry peers · Fliar Intelligence Index 83/100 | $217M | 10 mo ago | $48M FY2025 | — | 883 883 → 1,006 (+14%) · sector median +32% | Mahesh Pratapneni Co-Founder & Group CEO | 3 signals ▼57% Funding · Capital raise | — | 1 job opening |
| 5 | Beta Drugs Developer of therapeutics for oncology and dermatology 69Product top 14%Moat top 18%Fin. health top 26%Market top 29% All 11 signals ▾Producttop 14% Moattop 18% Fin. healthtop 26% Markettop 29% Innovationtop 34% Growthtop 40% Fundingtop 42% Talentbottom 49% Techbottom 39% Globalbottom 32% Newsbottom 21% Product: 7 distinct product lines · Company stage: Public Moat: Top 1% by revenue among 34 tracked Oncology companies · Editorial + unicorn rating 4/10 rank vs industry peers · Fliar Intelligence Index 69/100 | $14M | 18 mo ago | $44M FY2025 | +24% | 380 380 → 243 (-36%) · sector median +32% | Rahul Batra Chairman & Managing Director | — | — | — |
| 6 | Kapiva Provider of ayurvedic healthcare and nutritional products to improve health 87Market top 20%Moat top 20%News top 21%Funding top 24% All 10 signals ▾Markettop 20% Moattop 20% Newstop 21% Fundingtop 24% Growthtop 26% Talenttop 28% Techtop 30% Producttop 36% Fin. healthtop 41% Globalbottom 37% Market: 376 employees (top 4% of Life Sciences) · Revenue ~$41.3M Moat: Top 1% by revenue among 243 tracked Nutraceuticals Tech companies · Editorial + unicorn rating 8/10 rank vs industry peers · Fliar Intelligence Index 87/100 | $51M | 8 mo ago | $41M FY2025 | +49% | 376 376 → 526 (+40%) · sector median +32% | Shantanu Co-Founder | 9 signals ▲80% Funding · Fundraising · Capital raise | — | 1 expansion |
| 7 | Botanic Healthcare Develops natural ingredients for use across health, food, ayurvedic botanical, and cosmetic industries 64Moat top 19%Market top 30%Fin. health top 35%Talent top 37% All 9 signals ▾Moattop 19% Markettop 30% Fin. healthtop 35% Talenttop 37% Fundingtop 41% Growthtop 43% Techbottom 44% Newsbottom 44% Globalbottom 32% Moat: Top 2% by revenue among 243 tracked Nutraceuticals Tech companies · Editorial + unicorn rating 4/10 Market: 310 employees (top 5% of Life Sciences) · Revenue ~$33.1M rank vs industry peers · Fliar Intelligence Index 64/100 | $30M | 17 mo ago | $33M FY2025 | +10% | 310 310 → 325 (+5%) · sector median +32% | Madhu Krishnamani Co-Founder & MD | 3 signals ▼40% Leadership · Capital raise | — | 1 internship · 1 launch |
| 8 | Fullife Manufacturer of effervescent nutritional and pharmaceutical products 69Moat top 19%Product top 21%News top 22%Funding top 27% All 11 signals ▾Moattop 19% Producttop 21% Newstop 22% Fundingtop 27% Fin. healthtop 32% Innovationtop 34% Markettop 36% Growthtop 38% Talenttop 38% Globalbottom 39% Techbottom 34% Moat: Top 2% by revenue among 243 tracked Nutraceuticals Tech companies · Editorial + unicorn rating 8/10 Product: 4 distinct product lines · Company stage: Series D rank vs industry peers · Fliar Intelligence Index 69/100 | $45M | 2 mo ago | $31M FY2025 | +35% | 100 | Varun Khanna Co-Founder | 5 signals ▲400% Funding · Capital raise | — | — |
| 9 | SS Innovations International Developer of healthcare professional robots 72Growth top 18%News top 26%Moat top 27%Fin. health top 31% All 9 signals ▾Growthtop 18% Newstop 26% Moattop 27% Fin. healthtop 31% Markettop 33% Fundingtop 48% Globalbottom 43% Productbottom 40% Techbottom 34% Growth: Headcount 95 → 216 (+127%) across vintages · Revenue +68% YoY News: 9 BI events in 12 mo (of 16 tracked, 5 types) · +80% YoY rank vs industry peers · Fliar Intelligence Index 72/100 | $2M | 3 mo ago | $24M FY2025 | +68% | 216 216 → 453 (+110%) · sector median +32% | — | 9 signals ▲80% Earnings · Funding | — | — |
| 10 | Wellbeing Nutrition Provider of organic whole-food nutritional supplements 72Growth top 18%Tech top 24%News top 25%Funding top 32% All 10 signals ▾Growthtop 18% Techtop 24% Newstop 25% Fundingtop 32% Moattop 34% Producttop 42% Markettop 43% Fin. healthtop 49% Talentbottom 48% Globalbottom 37% Growth: Headcount 34 → 108 (+218%) across vintages · Revenue +65% YoY Tech: 57 technologies across 5/8 capability areas · Cloud: Akamai, Amazon S3 rank vs industry peers · Fliar Intelligence Index 72/100 | $14M | 3 mo ago | $14M FY2025 | +65% | 108 108 → 196 (+81%) · sector median +32% | Saurabh Kapoor Co-Founder | 20 signals ▲150% M&A · Earnings · Leadership | — | — |
| 11 | Panacea Developer of devices for radiotherapy 50Moat top 22%Market top 38%Talent top 38%Fin. health top 39% All 8 signals ▾Moattop 22% Markettop 38% Talenttop 38% Fin. healthtop 39% Fundingtop 42% Growthtop 48% Globalbottom 37% Techbottom 19% Moat: Top 6% by revenue among 34 tracked Oncology companies · Editorial + unicorn rating 5/10 Market: 336 employees (top 4% of Life Sciences) · Revenue ~$11.8M rank vs industry peers · Fliar Intelligence Index 50/100 | $10M | 17 mo ago | $12M FY2025 | +1% | 336 | Raghu Padmanabhan Co-Founder & CEO | — | — | — |
| 12 | The Good Bug Provider of personalised synbiotic supplements and fermented products for gut health 67Growth top 24%Moat top 29%Market top 37%Talent top 38% All 10 signals ▾Growthtop 24% Moattop 29% Markettop 37% Talenttop 38% Fin. healthtop 41% Fundingtop 44% Producttop 46% Techbottom 44% Globalbottom 37% Newsbottom 18% Growth: Headcount 41 → 95 (+132%) across vintages · Revenue +104% YoY Moat: Top 7% by revenue among 243 tracked Nutraceuticals Tech companies · Editorial + unicorn rating 5/10 rank vs industry peers · Fliar Intelligence Index 67/100 | $8M | 13 mo ago | $11M FY2025 | +104% | 95 95 → 74 (-22%) · sector median +32% | Keshav Biyani Co-Founder | — | — | 1 job opening |
| 13 | Futura Surgicare Manufacturer of wound closure products and sterile sutures 60Moat top 22%Market top 30%Funding top 43%Fin. health top 43% All 7 signals ▾Moattop 22% Markettop 30% Fundingtop 43% Fin. healthtop 43% Growthtop 48% Globalbottom 32% Newsbottom 21% Moat: Top 17% by revenue among 23 tracked Surgical Instruments companies · Editorial + unicorn rating 7/10 Market: 381 employees (top 3% of Life Sciences) · Revenue ~$10.6M rank vs industry peers · Fliar Intelligence Index 60/100 | $25M | 23 mo ago | $11M FY2025 | +9% | 381 | — | — | — | — |
| 14 | PopVax Developer of mRNA platform for vaccines and therapeutics 74Growth top 18%Moat top 28%Tech top 31%Fin. health top 36% All 11 signals ▾Growthtop 18% Moattop 28% Techtop 31% Fin. healthtop 36% Patentstop 39% Fundingtop 42% Innovationtop 45% AItop 45% Markettop 46% Talentbottom 49% Globalbottom 37% Growth: Headcount 24 → 50 (+108%) across vintages · Revenue +45% YoY Moat: Top 14% by revenue among 42 tracked Infectious Diseases companies · Editorial + unicorn rating 3/10 rank vs industry peers · Fliar Intelligence Index 74/100 | $6M | 9 mo ago | $7M FY2025 | +45% | 50 50 → 79 (+58%) · sector median +32% | Soham Sankaran Founder & CEO & Managing Director | — | 22 patents Multisubunit viral subunit vaccines delivered via lipid nanoparticle nucleic acid platforms | 1 launch |
| 15 | Samplify Providing seamless sample collection and management services to hospitals and diagnostic centers 62Fin. health top 23%Moat top 23%Talent top 28%Tech top 37% All 10 signals ▾Fin. healthtop 23% Moattop 23% Talenttop 28% Techtop 37% Producttop 38% Innovationtop 39% Markettop 40% Fundingtop 49% Globalbottom 37% Growthbottom 36% Fin. health: Revenue ~$6.7M (FY2025) · Net margin 15.0% Moat: Top 8% by revenue among 98 tracked Life Sciences Tech companies · Editorial + unicorn rating 4/10 rank vs industry peers · Fliar Intelligence Index 62/100 | $5M | 8 mo ago | $7M FY2025 | — | 110 110 → 137 (+25%) · sector median +32% | Nitin Reja Co-Founder | — | — | — |
| 16 | Forus Health Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms 69Innovation top 25%Moat top 27%Patents top 31%Product top 32% All 12 signals ▾Innovationtop 25% Moattop 27% Patentstop 31% Producttop 32% Fundingtop 33% Newstop 36% Talenttop 38% Markettop 40% Fin. healthtop 40% Growthtop 42% Globalbottom 44% Techbottom 43% Innovation: 41 patents (top 30% of patent-holders) · 14 filings since 2022 vs 9 in 2017-21 Moat: Top 19% by revenue among 27 tracked Ophthalmology companies · Editorial + unicorn rating 7/10 rank vs industry peers · Fliar Intelligence Index 69/100 | $18M | 7 mo ago | $6M FY2025 | +13% | 121 | Shyam Vasudevarao Co-Founder & Director | — | 37 patents Portable retinal imaging systems with annular illumination for neonatal and clinical eye diagnostics | 1 launch |
| 17 | 1Cell.Ai Developer of AI-powered single-cell multi-omic analysis tools for precision oncology 69Growth top 20%Market top 43%Funding top 44%AI top 45% All 9 signals ▾Growthtop 20% Markettop 43% Fundingtop 44% AItop 45% Producttop 47% Techtop 48% Talentbottom 49% Fin. healthbottom 48% Globalbottom 45% Growth: Revenue +95% YoY · Web rank 10,000,000 → 5,000,000 YoY Market: Revenue ~$5.0M · Top 8% by revenue among 130 tracked Genomics peers rank vs industry peers · Fliar Intelligence Index 69/100 | $16M | 18 mo ago | $5M FY2025 | +95% | — | Mohan Uttarwar Co-Founder & CEO | — | — | — |
| 18 | Zeroharm Provider of multiple health and nutritional supplements 67Growth top 18%Tech top 30%Moat top 32%Fin. health top 38% All 8 signals ▾Growthtop 18% Techtop 30% Moattop 32% Fin. healthtop 38% Fundingtop 45% Markettop 49% Talentbottom 49% Globalbottom 32% Growth: Revenue +130% YoY · Fresh capital in last 24 mo Tech: 40 technologies across 5/8 capability areas · Cloud: Amazon S3, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 67/100 | $20M | 3 mo ago | $5M FY2025 | +130% | — | Sachin Darbarwar Co-Founder | — | — | 1 job opening · 1 internship |
| 19 | HRS Navigation Manufacturer of surgical navigation systems for cranial, spinal, and ENT surgeries 67Innovation top 23%Growth top 31%Tech top 38%Moat top 38% All 10 signals ▾Innovationtop 23% Growthtop 31% Techtop 38% Moattop 38% Talenttop 38% Producttop 43% Fin. healthtop 47% Markettop 48% Fundingbottom 47% Globalbottom 32% Innovation: 9 product lines · Deep-tech classification: Tech Hardware Growth: Headcount 64 → 89 (+39%) across vintages · Revenue +37% YoY rank vs industry peers · Fliar Intelligence Index 67/100 | $8M | 7 mo ago | $3M FY2025 | +37% | 89 89 → 102 (+15%) · sector median +32% | Arpit Paliwal Co-Founder & CEO & Director | — | — | 1 job opening · 1 launch |
| 20 | UnivLabs Designer and manufacturer of Endoscopy Devices 69Growth top 18%Innovation top 34%Fin. health top 37%Talent top 38% All 10 signals ▾Growthtop 18% Innovationtop 34% Fin. healthtop 37% Talenttop 38% Techtop 42% Producttop 43% Markettop 47% Moatbottom 49% Fundingbottom 40% Globalbottom 32% Growth: Headcount 14 → 101 (+621%) across vintages · Revenue +171% YoY Innovation: 12 product lines rank vs industry peers · Fliar Intelligence Index 69/100 | $5M | 14 mo ago | $3M FY2025 | +171% | 101 101 → 104 (+3%) · sector median +32% | Anil Mandhani Co-Founder | — | — | 1 award |
| 21 | S3V Vascular Technologies Developer of cardiovascular surgical and critical care devices 35Talent top 38%Growth top 42%Moat top 46%Funding top 48% All 9 signals ▾Talenttop 38% Growthtop 42% Moattop 46% Fundingtop 48% Marketbottom 46% Fin. healthbottom 44% Globalbottom 37% Newsbottom 22% Techbottom 15% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Growth: Headcount 43 → 67 (+56%) across vintages · Revenue +5% YoY rank vs industry peers · Fliar Intelligence Index 35/100 | $42M | 27 mo ago | $2M FY2025 | +5% | 67 67 → 134 (+100%) · sector median +32% | Vijaya Nagaradagadde Co-Founder & Director | — | — | — |
| 22 | Decode Age Online retailer of longevity supplements and provider of microbiome tests 60Tech top 24%Growth top 27%Talent top 28%Innovation top 33% All 10 signals ▾Techtop 24% Growthtop 27% Talenttop 28% Innovationtop 33% Moattop 37% Producttop 43% Fundingbottom 46% Marketbottom 39% Fin. healthbottom 39% Globalbottom 37% Tech: 51 technologies across 5/8 capability areas · Cloud: Akamai, Amazon Ses Growth: Revenue +26% YoY · Web rank 1,000,000 → 500,000 YoY rank vs industry peers · Fliar Intelligence Index 60/100 | $274K | 6 mo ago | $2M FY2025 | +26% | 8 | Rakesh Somani Co-Founder & COO | — | — | — |
| 23 | Zeus Hygia Manufacturer of science-backed nutraceutical ingredients for food, pharmaceutical, and cosmetic industries 57Growth top 28%Moat top 32%Innovation top 34%Product top 36% All 10 signals ▾Growthtop 28% Moattop 32% Innovationtop 34% Producttop 36% Fin. healthtop 38% Techtop 49% Talentbottom 49% Marketbottom 43% Fundingbottom 41% Globalbottom 37% Growth: Revenue +59% YoY · Fresh capital in last 24 mo Moat: Top 24% by revenue among 243 tracked Nutraceuticals Tech companies · Editorial + unicorn rating 4/10 rank vs industry peers · Fliar Intelligence Index 57/100 | $3M | 14 mo ago | $2M FY2025 | +59% | — | Shankaranarayanan Jeyakodi Co-Founder | — | — | 2 launchs |
| 24 | 4baseCare Provider of precision oncology solutions, including genomic testing and digital health 50Moat top 33%Innovation top 34%Funding top 35%Product top 36% All 11 signals ▾Moattop 33% Innovationtop 34% Fundingtop 35% Producttop 36% Talenttop 38% Techtop 43% Globalbottom 49% Growthbottom 47% Newsbottom 44% Marketbottom 43% Fin. healthbottom 37% Moat: Top 15% by revenue among 130 tracked Genomics companies · Editorial + unicorn rating 5/10 Innovation: 12 product lines rank vs industry peers · Fliar Intelligence Index 50/100 | $8M | 4 mo ago | $2M FY2025 | — | 25 | Hitesh Goswami Co-Founder & CEO | 3 signals ▼62% Funding · Capital raise | — | — |
| 25 | Immuneel Developer of T-cell therapies for the treatment of cancer 40Moat top 31%Funding top 40%Growth top 46%Market top 49% All 9 signals ▾Moattop 31% Fundingtop 40% Growthtop 46% Markettop 49% Talentbottom 49% Fin. healthbottom 44% Globalbottom 39% Techbottom 31% Newsbottom 18% Moat: Top 21% by revenue among 34 tracked Oncology companies · Editorial + unicorn rating 7/10 Funding: Raised $39.3M across 4 rounds · 4 rounds over 7 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 40/100 | $39M | 23 mo ago | $1M FY2025 | +342% | 67 67 → 112 (+67%) · sector median +32% | Siddhartha Mukherjee Co-Founder | — | — | — |
| 26 | Earthful Platform offering plant-based nutritional supplements and wellness products 55Growth top 21%Tech top 31%News top 36%Talent top 38% All 9 signals ▾Growthtop 21% Techtop 31% Newstop 36% Talenttop 38% Moattop 40% Fundingbottom 46% Fin. healthbottom 46% Marketbottom 38% Globalbottom 37% Growth: Revenue +209% YoY · Fresh capital in last 24 mo Tech: 36 technologies across 5/8 capability areas · Cloud: Amazon S3, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 55/100 | $477K | 7 mo ago | $1M FY2025 | +209% | — | Veda Gogineni Co-Founder | 5 signals ▲25% Funding | — | 2 job openings · 1 internship |
| 27 | SigTuple Provider of AI-powered diagnostic solutions for laboratories and hospitals 72Moat top 23%Funding top 25%AI top 26%Talent top 28% All 10 signals ▾Moattop 23% Fundingtop 25% AItop 26% Talenttop 28% Growthtop 36% Techtop 38% Markettop 47% Fin. healthbottom 44% Globalbottom 39% Newsbottom 21% Moat: Top 9% by revenue among 46 tracked Computer Vision companies · Editorial + unicorn rating 8/10 Funding: Raised $54.7M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 72/100 | $55M | 22 mo ago | $1M FY2025 | +64% | 95 95 → 101 (+6%) · sector median +32% | Pranat Bhadani Co-Founder & Business Head | — | — | 1 award |
| 28 | HaystackAnalytics Provider of genomics technology for personalized clinical decisions 60Growth top 17%Talent top 28%Moat top 38%Funding top 47% All 10 signals ▾Growthtop 17% Talenttop 28% Moattop 38% Fundingtop 47% Markettop 48% Techtop 49% Innovationbottom 47% Patentsbottom 47% Fin. healthbottom 45% Globalbottom 39% Growth: Revenue +177% YoY · Web rank 10,000,000 → 5,000,000 YoY Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 60/100 | $1M | 8 mo ago | $838K FY2025 | +177% | 151 151 → 266 (+76%) · sector median +32% | Kiran Kondabagil Co-Founder | — | 3 patents Molecular diagnostics for pathogen and antibiotic resistance gene detection | 1 award |
| 29 | EzeRx Manufacturer of non-invasive, IoT-enabled medical diagnostic devices. 45Innovation top 27%Talent top 28%Moat top 34%Product top 45% All 11 signals ▾Innovationtop 27% Talenttop 28% Moattop 34% Producttop 45% Techtop 50% Growthbottom 49% Fundingbottom 43% Marketbottom 42% Fin. healthbottom 35% Globalbottom 32% Newsbottom 27% Innovation: 3 product lines · Deep-tech classification: Tech Hardware Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 45/100 | $4M | 17 mo ago | $759K FY2025 | -34% | 45 | Sudip Chowdhury Co-Founder | — | — | 1 launch |
| 30 | GangaGen Develop drugs for the prevention and treatment of bacterial infections that are resistant to antibiotics 27Product top 36%Moat top 39%Growth top 46%Funding top 47% All 11 signals ▾Producttop 36% Moattop 39% Growthtop 46% Fundingtop 47% Talentbottom 49% Globalbottom 47% Fin. healthbottom 42% Marketbottom 40% Patentsbottom 38% Innovationbottom 34% Techbottom 30% Product: 2 distinct product lines · Company stage: Acquired Moat: Top 40% by revenue among 42 tracked Infectious Diseases companies · Editorial + unicorn rating 5/10 rank vs industry peers · Fliar Intelligence Index 27/100 | $13M | 17 mo ago | $712K FY2022 | +48% | 37 37 → 68 (+84%) · sector median +32% | Janakiraman Ramachandran Chairman & CEO | — | 16 patents Phage‑based antimicrobial therapeutics and engineered antibacterial peptides for bacterial infections | — |
| 31 | Janitri Developer of fetal, maternal, and newborn health monitoring solutions 42Tech top 34%Moat top 37%Growth top 40%Funding top 46% All 9 signals ▾Techtop 34% Moattop 37% Growthtop 40% Fundingtop 46% Talentbottom 49% Marketbottom 45% Productbottom 45% Globalbottom 39% Fin. healthbottom 27% Tech: 35 technologies across 5/8 capability areas · Cloud: Cloudflare Moat: Top 23% by revenue among 830 tracked Healthcare IT companies · Editorial + unicorn rating 5/10 rank vs industry peers · Fliar Intelligence Index 42/100 | $2M | 14 mo ago | $609K FY2025 | — | 46 | Arun Agarwal Founder & CEO | — | — | — |
| 32 | Monitra Healthcare Ambulatory cardiac monitoring devices and solutions 45Growth top 25%Product top 36%Talent top 38%Moat top 42% All 12 signals ▾Growthtop 25% Producttop 36% Talenttop 38% Moattop 42% Fundingtop 45% Techtop 47% Globalbottom 42% Innovationbottom 40% Fin. healthbottom 39% Marketbottom 37% Patentsbottom 35% Newsbottom 22% Growth: Headcount 40 → 53 (+32%) across vintages · Revenue +89% YoY Product: 4 distinct product lines · Company stage: Series A rank vs industry peers · Fliar Intelligence Index 45/100 | $3M | 8 mo ago | $595K FY2025 | +89% | 53 53 → 64 (+21%) · sector median +32% | Aparna Bhogu Co-Founder | — | 7 patents Wireless, wearable cardiac telemetry devices for real-time physiological signal acquisition and transmission. | 1 award |
| 33 | Zumutor Developer of novel immunotherapy and monoclonal antibody therapeutics 22Innovation top 34%Product top 36%Funding top 42%Tech top 50% All 10 signals ▾Innovationtop 34% Producttop 36% Fundingtop 42% Techtop 50% Globalbottom 43% Moatbottom 40% Growthbottom 33% Marketbottom 29% Newsbottom 27% Fin. healthbottom 16% Innovation: 4 product lines Product: 4 distinct product lines · Company stage: Series A rank vs industry peers · Fliar Intelligence Index 22/100 | $26M | 18 mo ago | $547K FY2025 | -64% | 24 24 → 25 (+4%) · sector median +32% | — | — | — | — |
| 34 | Rymo Technologies Developer of virtual reality and gaming-based systems for mobility rehabilitation 48Growth top 18%Talent top 38%Tech top 42%Funding top 47% All 8 signals ▾Growthtop 18% Talenttop 38% Techtop 42% Fundingtop 47% Moatbottom 49% Fin. healthbottom 42% Globalbottom 32% Marketbottom 30% Growth: Revenue +126% YoY · Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 48/100 | $343K | 3 mo ago | $514K FY2025 | +126% | 23 23 → 35 (+52%) · sector median +32% | Abhishek Rai Co-Founder & CTO | — | — | — |
| 35 | Pandorum Developer of regenerative medicine and 3D tissues 50News top 28%Funding top 30%Growth top 32%Moat top 36% All 9 signals ▾Newstop 28% Fundingtop 30% Growthtop 32% Moattop 36% Talenttop 38% Techbottom 47% Fin. healthbottom 45% Globalbottom 44% Marketbottom 40% News: 4 BI events in 12 mo (of 17 tracked, 1 types) · Top themes: Funding Funding: Raised $27.1M across 10 rounds · 10 rounds over 11 yrs (0.9/yr) rank vs industry peers · Fliar Intelligence Index 50/100 | $27M | 2 mo ago | $417K FY2025 | +322% | 26 26 → 44 (+69%) · sector median +32% | Tuhin Bhowmick Co-Founder & CEO & Director | 4 signals Funding | — | — |
| 36 | Eyestem Developer of cell replacement therapies to treat ophthamological conditions 22Talent top 28%Product top 40%Innovation top 43%Funding top 43% All 11 signals ▾Talenttop 28% Producttop 40% Innovationtop 43% Fundingtop 43% Growthbottom 46% Moatbottom 43% Globalbottom 37% Techbottom 27% Newsbottom 27% Marketbottom 25% Fin. healthbottom 14% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Product: 2 distinct product lines · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 22/100 | $10M | 10 mo ago | $252K FY2025 | -27% | 1 | Rajarshi Pal Co-Founder | — | — | 1 job opening · 2 awards |
| 37 | Swap Platform offering customized nutritional diet plans 40Tech top 35%Talent top 35%Funding top 43%Moat top 45% All 9 signals ▾Techtop 35% Talenttop 35% Fundingtop 43% Moattop 45% Growthbottom 49% Productbottom 40% Globalbottom 36% Fin. healthbottom 36% Marketbottom 28% Tech: 32 technologies across 5/8 capability areas · Cloud: Cloudflare, Google Cloud Talent: 3 named leaders on record rank vs industry peers · Fliar Intelligence Index 40/100 | $897K | 1 mo ago | $249K FY2025 | +5% | — | Anurag Prithvi Co-Founder | — | — | — |
| 38 | Peptris Provider of AI-based proteomic data analysis software for drug discovery 69Growth top 18%AI top 23%Talent top 28%News top 38% All 10 signals ▾Growthtop 18% AItop 23% Talenttop 28% Newstop 38% Fin. healthtop 42% Fundingtop 43% Moattop 50% Techbottom 47% Marketbottom 38% Globalbottom 37% Growth: Revenue +305% YoY · Fresh capital in last 24 mo AI: Classified as an agentic-AI company · Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 69/100 | $1M | 5 mo ago | $228K FY2025 | +305% | — | Narayanan Venkatasubramanian Co-Founder & CEO | 3 signals Funding · Capital raise | — | 2 job openings |
| 39 | Ahammune Biosciences Private Limited Developer of small molecule based therapeutics for the treatment of skin diseases 37Growth top 20%Talent top 38%Patents top 47%Moat top 47% All 11 signals ▾Growthtop 20% Talenttop 38% Patentstop 47% Moattop 47% Techtop 48% Fundingtop 49% Innovationbottom 42% Globalbottom 40% Fin. healthbottom 37% Marketbottom 22% Newsbottom 18% Growth: Revenue +173% YoY · Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 37/100 | $8M | 20 mo ago | $139K FY2025 | +173% | 10 | Krishnamurthy Natarajan Co-Founder | — | 27 patents Design and synthesis of heterocyclic small‑molecule therapeutics for autoimmune disease treatment | — |
| 40 | CrisprBits Developer of diagnostic tests based on gene editing technology 42Growth top 21%Talent top 28%Tech top 36%News top 36% All 11 signals ▾Growthtop 21% Talenttop 28% Techtop 36% Newstop 36% Moattop 47% Patentsbottom 46% Innovationbottom 44% Fundingbottom 43% Fin. healthbottom 38% Globalbottom 37% Marketbottom 25% Growth: Revenue +249% YoY · Fresh capital in last 24 mo Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 42/100 | $447K | 6 mo ago | $99K FY2025 | +249% | — | Bharat Jobanputra Co-Founder | 3 signals Funding · Capital raise | 4 patents CRISPR‑based diagnostic assays for SARS‑CoV‑2 variants and host genetic susceptibility testing | 1 job opening · 2 launchs |
| 41 | Nowound Developer of medical device and technologies for wound closure and tissue regeneration 16Talent top 38%Growth top 45%Funding bottom 47%Global bottom 36% All 7 signals ▾Talenttop 38% Growthtop 45% Fundingbottom 47% Globalbottom 36% Marketbottom 30% Techbottom 28% Fin. healthbottom 11% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Growth: Web rank 10,000,000 → 50,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 16/100 | $3M | 7 mo ago | $79K FY2025 | — | — | Tarun Bansal Co-Founder & COO | — | — | — |
| 42 | Biopeak Provider of personalized health programs integrating diagnostics and multidisciplinary expertise 29Growth top 28%Talent top 38%Tech top 41%Funding top 49% All 8 signals ▾Growthtop 28% Talenttop 38% Techtop 41% Fundingtop 49% Moatbottom 37% Globalbottom 32% Marketbottom 24% Fin. healthbottom 12% Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 29/100 | $11M | 6 mo ago | $47K FY2025 | — | — | Shiva Subramanian Co-Founder & CTO | — | — | 1 job opening · 1 internship |
| 43 | Ykrita Life Sciences Developer of a bioengineered artificial ectopic liver device 6Talent top 35%Funding bottom 43%Growth bottom 32%Global bottom 29% All 6 signals ▾Talenttop 35% Fundingbottom 43% Growthbottom 32% Globalbottom 29% Marketbottom 9% Fin. healthbottom 5% Talent: 3 named leaders on record Funding: Raised $1.9M across 6 rounds · 6 rounds over 6 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 6/100 | $2M | 12 mo ago | $22K FY2025 | -85% | — | Mahesh Gopasetty Co-Founder | — | — | — |
| 44 | immunitoAI Developer of AI-based platform for antibody discovery and therapeutics 16AI top 30%Funding top 38%Talent top 38%Growth bottom 43% All 9 signals ▾AItop 30% Fundingtop 38% Talenttop 38% Growthbottom 43% Globalbottom 37% Moatbottom 30% Marketbottom 22% Techbottom 22% Fin. healthbottom 13% AI: Classified as an AI company · Product described with: ai-based Funding: Raised $1.0M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 16/100 | $1M | 8 mo ago | $7K FY2025 | -87% | 22 22 → 25 (+14%) · sector median +32% | Trisha Chatterjee Co-Founder & CTO | — | — | — |
| 45 | The Stack Retailer of supplements formulated for sleep, gut health, and immunity 22Growth top 20%Talent top 38%Tech top 48%Funding bottom 42% All 7 signals ▾Growthtop 20% Talenttop 38% Techtop 48% Fundingbottom 42% Globalbottom 36% Marketbottom 16% Fin. healthbottom 7% Growth: Web rank 10,000,000 → 1,000,000 YoY · Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 22/100 | $608K | 5 mo ago | $6K FY2025 | — | — | Kshitij Rihal Co-Founder | — | — | 2 job openings |
| 46 | Cellogen Therapeutics Developer of cellular engineering methods and gene therapy based treatments 35Growth top 35%Patents top 47%Moat bottom 49%Talent bottom 49% All 9 signals ▾Growthtop 35% Patentstop 47% Moatbottom 49% Talentbottom 49% Techbottom 48% Fundingbottom 47% Innovationbottom 46% Globalbottom 36% Marketbottom 29% Growth: Fresh capital in last 24 mo Patents: 6 patents matched (strict assignee match) · 6 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 35/100 | $2M | 1 mo ago | — | — | — | Gaurav Kharya Founder | — | 6 patents CAR-T cell engineering targeting B‑cell malignancies for immunotherapy | — |
| 47 | RN Kids 35Talent top 45%Funding bottom 45%Global bottom 25% All 3 signals ▾Talenttop 45% Fundingbottom 45% Globalbottom 25% Talent: 2 named leaders on record Funding: Raised $760k across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 35/100 | $760K | 2 mo ago | — | — | — | Nihar Parekh Co-Founder | — | — | — |
| 48 | Lemnisca Developer of AI software for fermentation‑based production of biomolecules 45Talent top 45%Global bottom 48%Funding bottom 45%Tech bottom 44% All 4 signals ▾Talenttop 45% Globalbottom 48% Fundingbottom 45% Techbottom 44% Talent: 2 named leaders on record Global: Investors from 1 country beyond India rank vs industry peers · Fliar Intelligence Index 45/100 | $837K | 6 mo ago | — | — | — | Shilpa Nargund Co-Founder & CTO | — | — | — |
| 49 | Cache Provider of a platform for data storage and access to nucleic acids 14Funding top 47%Talent bottom 49%Tech bottom 47%Global bottom 38% All 5 signals ▾Fundingtop 47% Talentbottom 49% Techbottom 47% Globalbottom 38% Marketbottom 20% Funding: Raised $1.5M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 14/100 | $2M | 10 mo ago | — | — | 7 | James Banal Co-Founder | — | — | — |
| 50 | bioLOCKEY Healthworks Developer of point-of-care diagnostics and novel biologics by Nanobody discovery platform 16Funding top 43%Talent top 45%Tech bottom 43%Global bottom 36% All 5 signals ▾Fundingtop 43% Talenttop 45% Techbottom 43% Globalbottom 36% Marketbottom 13% Funding: Raised $143k across 5 rounds · 5 rounds over 3 yrs (1.7/yr) Talent: 2 named leaders on record rank vs industry peers · Fliar Intelligence Index 16/100 | $143K | 4 mo ago | — | — | — | Minhaj Sirajuddin Co-Founder & Director | — | — | — |
Top 12 Life Sciences companies in India
#1
Series D · Mumbai, Maharashtra · founded 2009 · 100 employees$45.4Mraised▾
Manufacturer of effervescent nutritional and pharmaceutical products. It offers proprietary HET technology to develop products which include sports nutrition, women wellness, and recovery tablets for post-party relief to reduce hangover effects. It also has strategic and exclusive in-licensing for novel healthcare formulations.
- Mar 2026Series D$32M
- Mar 2025Series C$3.3M
- Mar 2022Angel$261.4K
- Dec 2021Series C$22M
#2
Series B · Bengaluru, Karnataka · founded 2011 · 26 employees$27.1Mraised▾
Developer of regenerative medicine and 3D tissues. It has developed a working 3D tissue through 3D printing and fabrication techniques. The products include bioengineered cornea which is a hydrogel formulation used for blindness, 3D hepatocyte spheroids for drug discovery and liver therapies, and exosome cell-free therapy for lung regeneration.
- Mar 2026Series B$429.4K
- Oct 2025Series B$18M
- Jan 2024Series A$2M
- Aug 2023Series A$11M
#3
Series E · Bengaluru, Karnataka · founded 2013 · 883 employees$217Mraised▾
Provider of DNA sequencing, bioinformatics, and multiomics services. It offers a comprehensive suite of genomic services which include whole genome and exome sequencing, single-cell sequencing, spatial transcriptomics, and immune profiling. It also provides robust bioinformatics support, including analysis pipelines and data visualization tools, to facilitate research and drug discovery. The services are tailored to support research in various areas, including rare disease research, cancer research, and antibody discovery.
- Jul 2025Series E$47.5M
- Aug 2022Series D$50M
- Jul 2021Series D$16.5M
- Apr 2020Series D$55M
#4
Series A · Hyderabad, Telangana · founded 2020$19.9Mraised▾
Provider of multiple health and nutritional supplements. It offers a portfolio of supplements for diabetic care, cancer, gut health, cholestrol, anxiety, skin care, immunity, and others.
- Feb 2026Series A$7.1M
- Sep 2024Angel$3.4M
- Apr 2023Seed$1.9M
- Jul 2022Seed$417K
#5
Acquired · Mumbai, Maharashtra · founded 2019 · 108 employees$13.9Mraised▾
Provider of organic whole-food nutritional supplements. It offers a variety of supplements categorized by health benefit such as beauty, sports performance, weight management, and others, ingredient type includes proteins, collagen, vitamins. The products are formulated using scientifically-backed methods and traceable ingredients, emphasizing natural sources and avoiding artificial additives.
- Mar 2025Series B$2.9M
- Dec 2022Series B$10.3M
- 2022Venture Debt—
- Feb 2022Series A$432.9K
#6
Series D · Bengaluru, Karnataka · founded 2016 · 376 employees$50.5Mraised▾
Provider of ayurvedic healthcare and nutritional products to improve health. It offers a diverse portfolio of ayurvedic products, including ayurvedic juices, herbal capsules, gummies, powdered drinks, plant based proteins, cooking oils, hair, skin, and body oils. The products helps improve heart health, blood sugar and chronic care, weight management, skin care, and daily wellness products.
- Sep 2025Series D$28M
- Sep 2024Series C$10M
- Feb 2024Angel$106.9K
- Sep 2023Series B$11.8M
#7
Series B · Bengaluru, Karnataka · founded 2018 · 25 employees$8.1Mraised▾
Provider of precision oncology solutions, including genomic testing and digital health. It uses AI, cancer genomics, and real-world clinical data to personalize cancer treatment. It builds tools and lab solutions that help doctors and researchers understand a patients cancer at the genetic level and choose better treatments. The company provides comprehensive genome profiling to identify biomarkers for therapy resistance.
- Jan 2026Series B$9.8M
- Nov 2025Series A$991.4K
- Dec 2024Series A$3.4M
- Jul 2024Series A$6M
#8
Series B · Bengaluru, Karnataka · founded 2010 · 121 employees$18.1Mraised▾
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms. These devices are designed for acquiring, storing, and transmitting images of the eye's anterior and posterior segments, facilitating the diagnosis of various ocular diseases. The cloud-based platform integrates with the imaging devices, enabling remote diagnosis and efficient monitoring of patients. The company's technology aims to improve access to eye care, particularly in underserved areas. The devices are designed for ease of use and affordability, making them suitable for a wide range of healthcare settings.
- Nov 2025Series B—
- Jan 2020Series B$1.9M
- Oct 2018Series B$2.5M
- Mar 2018Series B$508K
#9
Series A · Bengaluru, Karnataka · founded 2024$11Mraised▾
Provider of personalized health programs integrating diagnostics and multidisciplinary expertise. The organization delivers advanced diagnostic services, personalized protocols, and multidisciplinary teams to optimize health. It uses a proprietary system to bring together science and personalized care. The company offers health strategies for individuals with health concerns, peak performers, and active health seekers. It analyzes health at cellular, tissue, organ, and system levels.
- Dec 2025Series A$3M
- Oct 2025Series A$880.9K
- Jul 2025Series A$3.5M
- May 2025Seed$1.2M
#10
Series A · Noida, Uttar Pradesh · founded 2021$1.9Mraised▾
Developer of cellular engineering methods and gene therapy based treatments. Research focuses on creating therapies for hematological malignancies, solid tumors, and blood disorders. Activities include the design of antigen targeting therapies and the application of gene editing techniques to modify hematopoietic stem cells. These approaches aim to address the underlying causes of inherited and metabolic conditions through cellular manipulation.
- May 2026Series A$2M
- Apr 2025Seed$885.6K
- Jan 2024Seed$1.8M
#11
Seed · Gurugram, Haryana · founded 2015 · 216 employees$2.5Mraised▾
Developer of healthcare professional robots. It manufactures surgical robotic systems, endosurgical instruments, mixed reality training, and multimedia recording. The company develops surgical robotic systems designed to make advanced surgical procedures accessible. It offers endosurgical instruments, mixed reality training modules, and multimedia recording and streaming technology. The company's surgical robotic system supports minimally invasive robotic procedures across multiple specialties.
- Mar 2026Post IPO$18.6M
- Feb 2024Seed$2.5M
#12
Seed · Bengaluru, Karnataka · founded 2015 · 89 employees$7.6Mraised▾
Manufacturer of surgical navigation systems for cranial, spinal, and ENT surgeries. The company provides surgical system platforms designed to meet specific surgical requirements. Its software suite supports cranial, spinal, and ENT procedures. The systems offer tools intended to optimize procedural outcomes.
- Nov 2025Seed$5M
- May 2022Seed$2.6M
- Aug 2017Grant (prize money)—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time flat
Funding & growth over time
funding flat · growth rising
How research on Biotechnology is moving in India
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 2,919 India-affiliated papers.
- Ministry of Agriculture118
- Tamil Nadu Agricultural University75
- Ministry of Education70
- Indian Agricultural Research Institute69
- Lovely Professional University47
- Gene1→40
- Genome1→20
- Antibody1→9
- Transcription factor1→9
- Downregulation and upregulation1→7
- Agriculture6→130
- Crop3→76
- Antimicrobial3→76
- Phytochemical1→67
- Nutraceutical2→66
- Agriculture9→64
- Antibiotic resistance2→38
- Human health1→32
- Food security3→31
- Antimicrobial2→30
Where biotechnology is researched across India
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in India
India biotechnology patent filing is cooling — 5,839 filings from 4,732 assignees (2016–2025), led by CSIR, Biocon, Cadila Healthcare; annual filings 590→491.
- CSIR1262
- Biocon689
- Cadila Healthcare397
- Bharat Biotech INT271
- Serum Institute Of India219
- Reliance LIFE Sciences213
- SUN Pharmaceutical IND197
- Reddys LAB DR177